Healive

Healive is the first inactivated hepatitis A vaccine developed in China by Chinese scientists who retained the intellectual property rights. It brought to an end an era in which China did not have its own technology for developing and producing inactivated Hepatitis A vaccine. Healive received the new drug certificate from the China State and Food Drug Administration in 1999, obtained final regulatory approval for production in May 2002 and was launched that same year.

• A WHO Prequalified Inactivated Hepatitis A Vaccine
• First Inactivated Hepatitis A Vaccine Developed in China
• Fast, Efficient and Long-lasting Immune Effectiveness
• Long Product Shelf Life: 42 months